Neuropeptide FF receptor 2 (NPFF2) is localized to pain-processing regions in the primate spinal cord and the lower level of the medulla oblongata

Journal of Chemical Neuroanatomy

Volumn 25, Issue 4, 2003, Pages 269-278

  Zeng, Zhizhen ^a   McDonald, Terrence P ^a   Wang, Ruiping ^a   Liu, Qingyun ^a   Austin, Christopher P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

African green monkey; Autoradiography; Immunohistochemistry; In situ hybridization; 125I 1DMe

Indexed keywords

NEUROPEPTIDE FF; NEUROPEPTIDE FF RECEPTOR 2; NEUROPEPTIDE RECEPTOR; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CELLULAR DISTRIBUTION; CERCOPITHECIDAE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MEDULLA OBLONGATA; MORPHINE TOLERANCE; NEUROMODULATION; NEUROPHYSIOLOGY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RABBIT; RNA PROBE; SENSORY STIMULATION; SPINAL CORD; SPINAL CORD DORSAL HORN; TRIGEMINAL NUCLEUS;

EID: 0038771133     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-0618(03)00038-3     Document Type: Article

References (51)

1. Allard M., Jordan D., Zajac J.M., Ries C., Martin D., Monkouanga D., Kopp N., Simonnet G. Autoradiographic localization of receptors for neuropeptide FF, FLFQPQRFamide, in human spinal sensory system. Brain Res. 633:1994;127-132.
2. Ballet S., Mauborgne A., Gouardères C., Bourgoin A.S., Zajac J.M., Hamon M., Cesselin F. The neuropeptide FF analogue, 1DMe, enhances in vivo met-enkephalin release from the rat spinal cord. Neuropharmacology. 38:1999;1317-1324.
3. Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., Smith K.E., Tamm J.A., Boteju L.W., Lakhlani P.P., Raddatz R., Yao W.J., Ogozalek K.L., Boyle N., Kouranova E.V., Quan Y., Vaysse P.J., Wetzel J.M., Branchek T.A., Gerald C., Borowsky B. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J. Biol. Chem. 275:(50):2000;39324-39331.
4. Bonnard E., Burlet-Schiltz O., Frances B., Mazarguil H., Monsarrat B., Zajac J.M., Roussin A. Identification of neuropeptide FF-related peptides in rodent spinal cord. Peptides. 22:2001;1085-1092.
5. Courteix C., Cudore-Civiale M.A., Privat A.M., Zajac J.M., Eschalier A., Fialip J. Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats. Br. J. Pharmacol. 127:1999;1454-1462.
6. Deinard A., Smith D.G. Phylogenetic relationships among the macaques: evidence from the nuclear locus NRAMP1. J. Hum. Evol. 41:2001;45-59.
7. Desprat C., Zajac J.M. Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain. Dev. Brain Res. 82:1994;118-126.
8. Devillers J.P., Mazarguil H., Allard M., Dickenson A.H., Zajac J.M., Simmonet G. Characterization of a potent agonist for NPFF receptors: binding study in rat spinal cord membranes. Neuropharmacology. 33:(5):1994;661-669.
9. Dupouy V., Puget A., Eschalier A., Zajac J.M. Species differences in the localization of neuropeptide FF receptors in rodent and lagomorph brain and spinal cord. Peptides. 17:1996;399-405.
10. Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K., Szekeres P.G., Evans N.A., Schmidt D.B., Buckley P.T., Dytko G.M., Murdock P.R., Milligan G., Groarke D.A., Tan K.B., Shabon U., Nuthulaganti P., Wang D.Y., Wilson S., Bergsma D.J., Sarau H.M. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J. Biol. Chem. 275:(34):2000;25965-25971.
11. Gelot A., Frances B., Roussin A., Latapie J.P., Zajac J.M. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice. Brain Res. 808:1998;166-173.
12. Gelot A., Mazarguil H., Dupuy P., Frances B., Gouardères C., Roumy M., Zajac J.M. Biochemical, cellular and pharmacological activities of a human neuropeptide FF-related peptide. Eur. J. Pharmacol. 354:1998;167-172.
13. Gherardi N., Zajac J.M. Neuropeptide FF receptors of mouse olfactory bulb: binding properties and stimulation of adenylate cyclase activity. Peptides. 18:1997;577-583.
14. Gicquel S., Mazarguil H., Allard M., Simonnet G., Zajac J.M. Analogs of F8Famide resistant to degradation, with high affinity and in vivo effects. Eur. J. Pharmacol. 222:1992;61-67.
15. Gicquel S., Mazarguil H., Desprat C., Allard M., Devillers J.P., Simonnet G., Zajac J.M. Structure-activity study of neuropeptide FF: contribution of N-terminal regions to affinity and activity. J. Med. Chem. 37:1994;3477-3481.
16. Gouardères C., Sutak M., Zajac J.M., Jhamandas K. Antinociceptive effect of intrathecally administered F8Famide and FMRFamide in the rat. Eur. J. Pharmacol. 237:1993;73-81.
17. Gouardères C., Kar S., Zajac J.M. Presence of neuropeptide FF receptors on primary afferent fibers of the rat spinal cord. Neuroscience. 74:1996;21-27.
18. Gouardères C., Jhamandas K., Sutak M., Zajac J.M. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Br. J. Pharmacol. 117:1996;493-501.
19. 3]NPFF. Brain Res. Bull. 42:1997;231-238.
20. Gouardères C., Roumy M., Advokat C., Jhamandas K., Zajac J.M. Dual localization of neuropeptide FF receptors in the rat dorsal horn. Synapse. 35:2000;45-52.
21. Gouardères C., Mollereau C., Tafani J.A., Mazarguil H., Zajac J.M. (125I)EYE: a new high affinity radioligand to neuropeptide FF receptors. Peptides. 22:2001;623-629.
22. Gouardères C., Quelven I., Mollereau C., Mazarguil H., Rice S.Q.J., Zajac J.M. Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [125I]EYF as selective radioligands. Neuroscience. 115:2002;349-361.
23. Hinuma S., Shintani Y., Fukusumi S., Iijima N., Matsumoto Y., Hosoya M., Fujii R., Watanabe T., Kikuchi K., Terao Y., Yano T., Yamamoto T., Kawamata Y., Habata Y., Asada M., Kitada C., Kurokawa T., Onda H., Nishimura O., Tanaka M., Ibata Y., Fujino M. New neuropeptides containing carboxy-terminal Rfamide and their receptor in mammals. Natl. Cell. Biol. 2:2000;703-708.
24. Kavaliers M., Innes D. Sex differences in the effects of neuropeptide FF and IgG from neuropeptide FF on morphine- and stress-induced analgesia. Peptides. 13:1992;603-607.
25. 2-related peptides augments morphine- and stress-induced analgesia in mice. Peptides. 10:1989;741-745.
26. Kontine V.K., Kalso E.A. Differential modulation of I2-adrenergic and m-opioid spinal antinociception by neuropeptide FF. Peptides. 16:1995;973-977.
27. Kontinen A.K., Aarnisalo A.A., Idanpaan-Heikkila J.J., Panula P., Kalso E. Neuropeptide FF in the rat spinal cord during carrageenan inflammation. Peptides. 18:1997;287-292.
28. Kotani M., Mollereau C., Detheux M., Le Poul E., Brezillon S., Vakili J., Mazarguil H., Vassart G., Zajac J.M., Parmentier M. Functional characterization of human receptor for neuropeptide FF and related peptides. Br. J. Pharmacol. 133:2001;138-144.
29. Liu Q., Guan X.M., Martin W.J., McDonald T.P., Clements M.K., Jiang Q., Zeng Z., Jacobson M., Williams D.L., Yu H. Jr, Bomford D., Figueroa D., Mallee J., Wang R., Evans J., Gould R., Austin C.P. Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J. Biol. Chem. 276:2001;36961-36969.
30. Lombard M.-C., Wei-Fugazza J., Ries C., Allard M. Unilateral joint inflammation induces bilateral and time-dependent changes in neuropeptide FF binding in the superficial dorsal horn of the rat spinal cord: implication of supraspinal descending systems. Brain Res. 816:1999;598-608.
31. Majane E.A., Yang H.Y.T. Distribution and characterization of two putative endogenous antagonist peptides in bovine brain. Peptides. 8:1987;657-662.
32. 2-like peptide in rat pituitary: decrease by osmotic stimulus. Peptides. 12:1991;1303-1308.
33. Mauborgne A., Bourgoin S., Polienor H., Roumy M., Simonnet G., Zajac J.M., Cesselin F. The neuropeptide FF analogue, 1DMe, acts as a functional opioid autoreceptor antagonist in the rat spinal cord. Eur. J. Pharmacol. 430:2001;273-276.
34. Mazarguil H., Gouardères C., Tafani J.M., Marcus D., Kotani M., Mollereau C., Roumy M., Zajac J.M. Structure-activity relationships of neuropeptide FF: role of C-terminal regions. Peptides. 22:2001;1471-1478.
35. Miller K.K., Lupica C.R. Neuropeptide FF inhibition of morphine effects in the rat hippocampus. Brain Res. 750:1997;81-86.
36. Mollereau C., Mazarguil H., Marcus D., Quelven I., Kotani M., Lannoy V., Dumont Y., Quirion R., Detheux M., Parmemtier M., Zajac J.M. Pharmacological characterization of human NPFF1 and NPFF2 receptors expressed in CHO cells by using NPY Y1 receptor antagonists. Eur. J. Pharmacol. 451:2002;245-256.
37. Murase T., Arima H., Kondo K., Oiso Y. Neuropeptide FF reduces food intake in rats. Peptides. 17:1995;353-354.
38. Nieminen M.L., Brandt A., Pietilä P., Panula P. Expression of mammalian RF-amide peptides neuropeptide FF (NPFF), prolactin-releasing peptide (PrRP) and PrRP receptor in the peripheral tissues of the rat. Peptides. 21:2000;1695-1701.
39. Nystedt J.M., Brandt A.M., Mandelin J., Vilim F.S., Ziff E.B., Panula P. Analysis of human neuropeptide FF gene expression. J. Neurochem. 82:2002;1330-1342.
40. Panula P., Kivipelto L., Nieminen O., Majane E.A., Yang H.Y.T. Neuroanatomy of morphine-modulating peptides. Med. Biol. 65:1987;127-135.
41. Panula P., Aarmisalo A.A., Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog. Neurobiol. 48:1996;461-487.
42. Panula P., Kalso E., Nieminen M.L., Kontinen V.K., Brandt A., Pertovaara A. Neuropeptide FF and modulation of pain. Brain Res. 848:1999;191-196.
43. Payza K., Yang H.Y.T. Modulation of neuropeptide FF receptors by guanine nucleotides and cations in membranes of rat brain and spinal cord. J. Neurochem. 60:1993;1894-1899.
44. Perry S.J., Yi-Kung H.E., Cronk C., Bagust J., Sharma R., Walker R.J., Wilson S., Burke J.F. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett. 409:1997;426-430.
45. Quelven I., Roussin A., Burlet-Schiltz O., Gouardères C., Tafani J.A.M., Mazarguil H., Zajac J.M. Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs. Eur. J. Pharmacol. 449:2002;91-98.
46. 2 antiserum. Neuropeptides. 10:1987;37-42.
47. Roumy M., Gouardères C., Mazarguil H., Zajac J.M. Are neuropeptides FF and SF neurotransmitters in the rat. Biochem. Biophys. Res. Commun. 275:2000;821-824.
48. Tan P.P., Chen J.C., Li J.Y., Liang K.W., Wong C.H., Huang E.Y. Modulation of naloxone-precipitated morphine withdrawal syndromes in rats by neuropeptide FF analogs. Peptides. 20:1999;1211-1217.
49. Vilim F.S., Aarnisalo A.A., Nieminen M.L., Lintunen M., Karlstedt K., Kontinen V.K., Kalso E., States B., Panula P., Ziff E. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol. Pharmacol. 55:1999;804-811.
50. Xu M., Kontinen V.K., Panula P., Kalso E. Effects of (1DMe) NPYF, a synthetic neuropeptide FF analogue, in different pain models. Peptides. 20:1999;1071-1077.
51. Yang H.Y.T., Fratta W., Majane E.A., Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. USA. 82:1985;7757-7761.